In homozygous GFAP-Cre/RictorloxP/loxP mice 50% of animals developed tumors consistent with Grade I–II histopathology by 12–14 weeks and with 75% of animals succumbing to gliomas by 22 weeks. The gene discussed is GFAP; the disease is glioma.